(Q40671224)

22 September 2017

title

Establishment of a new human cell line (EN) with TP53 mutation derived from endometrial carcinoma (English)

1 reference

22 September 2017

0 references

Keiichi Isaka

1

1 reference

22 September 2017

Hirotaka Nishi

2

1 reference

22 September 2017

Yasukazu Sagawa

3

1 reference

22 September 2017

Toshihide Nakada

4

1 reference

22 September 2017

Yumi Osakabe

5

1 reference

22 September 2017

Hiromi Serizawa

6

1 reference

22 September 2017

Yoshiro Ebihara

7

1 reference

22 September 2017

Masaomi Takayama

8

1 reference

22 September 2017

language of work or name

1 reference

1 February 2003

1 reference

Cancer Genetics and Cytogenetics

22 September 2017

published in

1 reference

22 September 2017

volume

141

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

20-25

1 reference

describes a project that uses

22 September 2017

EN

0 references

cites work

Genetic alterations in endometrial hyperplasia and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Establishment and characterization of a highly tumorigenic human diploid endometrial cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Establishment and characterization of human cell lines from a serous papillary adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Establishment and characterization of six new human endometrial adenocarcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Establishment and characterization of CA 125 producing cell line (OMC-2) originating from a human endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Steroid hormones and medications that alter cancer risks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2802%2900673-8

7 January 2021

10.1016/S0165-4608(02)00673-8

Identifiers

DOI

1 reference

22 September 2017

1 reference